Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Sies, Helmut / Thomas, Douglas D. / Turk, Boris / Wittinghofer, Alfred

12 Issues per year


IMPACT FACTOR 2017: 3.022

CiteScore 2017: 2.81

SCImago Journal Rank (SJR) 2017: 1.562
Source Normalized Impact per Paper (SNIP) 2017: 0.705

Online
ISSN
1437-4315
See all formats and pricing
More options …
Volume 389, Issue 12

Issues

Quantitative expression analysis and prognostic significance of the novel apoptosis-related gene BCL2L12 in colon cancer

Christos K. Kontos
  • 1Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Athens, GR-15701 Athens, Greece
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Iordanis N. Papadopoulos
  • 24th Department of Surgery, ‘Attikon’ University Hospital, Faculty of Medicine, University of Athens, GR-15701 Athens, Greece
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Andreas Scorilas
  • 3Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Athens, GR-15701 Athens, Greece
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2008-10-09 | DOI: https://doi.org/10.1515/BC.2008.173

Abstract

Apoptosis is a tightly regulated process that plays a critical role in many biological events. Members of the BCL2 (Bcl-2) family of apoptosis-related genes have been found to be differentially expressed in various malignancies and have been proposed as prognostic tumor biomarkers. We have recently discovered and cloned a new member of the BCL2 gene family, BCL2L12, expressed in colon tissues. Here we have investigated expression of the BCL2L12 gene in colon cancer tissues and assessed its prognostic value. Total RNA was isolated from 96 specimens of malignant colon tissue. After testing the RNA quality, cDNA was prepared by reverse transcription. A highly sensitive real-time PCR method for BCL2L12 mRNA quantification was developed using SYBR® Green chemistry. GAPDH served as a housekeeping gene. Relative quantification analysis was performed using the comparative CT method (2-ΔΔCT). High BCL2L12 expression levels were found in smaller (≤5 cm, p=0.027) and well-differentiated tumors (p=0.034), as well as in early-stage tumors (p=0.039). Survival analysis demonstrated that patients with BCL2L12-positive colon tumors have significantly longer disease-free survival and overall survival (p=0.015 and p=0.027, respectively). Our results suggest that BCL2L12 gene expression may represent a potential new biomarker for colon cancer.

Keywords: apoptosis; BCL2 (Bcl-2) family; BCL2L12; real-time PCR; tumor biomarkers

About the article

Corresponding author


Received: 2008-06-17

Accepted: 2008-09-08

Published Online: 2008-10-09

Published in Print: 2008-12-01


Citation Information: Biological Chemistry, Volume 389, Issue 12, Pages 1467–1475, ISSN (Online) 1437-4315, ISSN (Print) 1431-6730, DOI: https://doi.org/10.1515/BC.2008.173.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[2]
Sabine Heumüller-Klug
World Journal of Gastroenterology, 2015, Volume 21, Number 12, Page 3499
[3]
David Hersi Smith, Ib Jarle Christensen, Niels Frank Jensen, Bo Markussen, Sven Müller, Hans Jørgen Nielsen, Nils Brünner, and Kirsten Vang Nielsen
BMC Cancer, 2013, Volume 13, Number 1
[4]
Marta Kinga Lemieszek, Miguel Ribeiro, Helena Guichard Alves, Guilhermina Marques, Fernando Milheiro Nunes, and Wojciech Rzeski
Food Funct., 2016, Volume 7, Number 7, Page 3163
[5]
Panagiotis G. Adamopoulos, Christos K. Kontos, Panagiotis Tsiakanikas, and Andreas Scorilas
Cancer Letters, 2016, Volume 373, Number 1, Page 119
[6]
C Nishioka, T Ikezoe, A Takeuchi, A Nobumoto, M Tsuda, and A Yokoyama
Leukemia, 2015, Volume 29, Number 12, Page 2296
[7]
Alexandros Tzovaras, Athina Kladi-Skandali, Kleita Michaelidou, George C. Zografos, Ioannis Missitzis, Alexandros Ardavanis, and Andreas Scorilas
Clinical Biochemistry, 2014, Volume 47, Number 18, Page 257
[8]
S. A. Jensen, E. S. Day, C. H. Ko, L. A. Hurley, J. P. Luciano, F. M. Kouri, T. J. Merkel, A. J. Luthi, P. C. Patel, J. I. Cutler, W. L. Daniel, A. W. Scott, M. W. Rotz, T. J. Meade, D. A. Giljohann, C. A. Mirkin, and A. H. Stegh
Science Translational Medicine, 2013, Volume 5, Number 209, Page 209ra152
[9]
Dimitra Florou, Christos Patsis, Alexandros Ardavanis, and Andreas Scorilas
Cancer Biology & Therapy, 2013, Volume 14, Number 7, Page 587
[10]
Spyros Foutadakis, Margaritis Avgeris, Theodoros Tokas, Konstantinos Stravodimos, and Andreas Scorilas
Urologic Oncology: Seminars and Original Investigations, 2014, Volume 32, Number 1, Page 39.e29
[11]
Mahdieh Sadat Taghavi, Azim Akbarzadeh, Reza Mahdian, Kayhan Azadmanesh, and Gholamreza Javadi
In Vitro Cellular & Developmental Biology - Animal, 2013, Volume 49, Number 6, Page 465
[12]
Dimitra K. Alexopoulou, Iordanis N. Papadopoulos, and Andreas Scorilas
Clinical Biochemistry, 2013, Volume 46, Number 15, Page 1453
[13]
Teodora Karan-Djurasevic, Vuk Palibrk, Branka Zukic, Vesna Spasovski, Irena Glumac, Milica Colovic, Natasa Colovic, Vladimir Jurisic, Andreas Scorilas, Sonja Pavlovic, and Natasa Tosic
Medical Oncology, 2013, Volume 30, Number 1
[14]
Panagiota-Aikaterini Geomela, Christos K. Kontos, Ioannis Yiotakis, and Andreas Scorilas
Journal of Oral Pathology & Medicine, 2013, Volume 42, Number 2, Page 154
[15]
Hellinida Thomadaki, Konstantinos V. Floros, Sonja Pavlovic, Natasa Tosic, Dimitrios Gourgiotis, Milica Colovic, and Andreas Scorilas
Clinical Biochemistry, 2012, Volume 45, Number 16-17, Page 1362
[18]
Howard C. Masuoka and Frank A. Sinicrope
Current Colorectal Cancer Reports, 2010, Volume 6, Number 3, Page 111

Comments (0)

Please log in or register to comment.
Log in